Related Experiment Videos
Controlled limb reperfusion in patients having cardiac operations
F Beyersdorf1, Z Mitrev, K Ihnken
1Department of Thoracic and Cardiovascular Surgery, Johann Wolfgang Goethe-University, Frankfurt, Germany.
The Journal of Thoracic and Cardiovascular Surgery
|April 1, 1996
Summary
Controlled limb reperfusion significantly reduces complications and mortality after cardiac surgery. This method salvages limbs and improves patient outcomes, demonstrating its clinical applicability.
Area of Science:
- Cardiovascular Surgery
- Vascular Surgery
- Critical Care Medicine
Background:
- Severe limb ischemia is a risk in cardiac surgery due to procedures like intraaortic balloon pump insertion and cardiopulmonary bypass.
- Normal reperfusion can lead to postischemic syndrome, increasing patient morbidity and mortality.
- Controlled reperfusion strategies aim to mitigate these risks.
Purpose of the Study:
- To test if controlled limb reperfusion reduces local and systemic complications compared to normal reperfusion.
- To evaluate the initial clinical application of controlled limb reperfusion in cardiac surgery patients.
- To assess the impact on postreperfusion syndrome and limb salvage.
Main Methods:
- Controlled limb reperfusion applied to 19 patients with severe prolonged ischemia, including those in cardiogenic shock.
- A 30-minute infusion of normothermic reperfusate mixed with arterial blood (6:1 ratio) into distal vessels.
- Data collected on patient outcomes, limb salvage, and systemic complications.
Main Results:
- 84% of patients survived with salvaged, functional limbs.
- No renal, cardiac, pulmonary, cerebral, or hemodynamic complications occurred in survivors.
- Deaths occurred only in patients with profound cardiogenic shock; no postischemic edema or contracture developed.
Conclusions:
- Controlled limb reperfusion is readily applicable using standard cardiac surgery equipment.
- This technique effectively salvages limbs in patients experiencing severe ischemia.
- Controlled limb reperfusion reduces postreperfusion morbidity and mortality in cardiac surgery patients.